Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) announces that the Biogenix Molecular Research ...
Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy human subjects ...
Sterotherapeutics, a leading biopharmaceutical company dedicated to advancing innovative therapies, is announcing the launch of a Phase 2 clinical trial for ST-002, a novel drug candidate for patients ...
LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a global leader in early clinical research, proudly announces a new agreement to relocate its U.K. Phase 1 clinical research operations to iREACH Health.
Trial decision follows unanticipated events of elevated unconjugated bilirubin levelsCompany advancing multiple next-generation PTH1R agonists ...
NexoBrid ® is a topically administered biological orphan drug that enzymatically removes eschar while preserving viable ...
Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...
Historically, clinical trials have under-represented women and minorities. Clinical Trial Media's Cara Brant offers ...
Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel ...
The US clinical trials market is extensively segmented by different phases of clinical research, service types, indications, and geographical landscapes. The segmentation is indicative of a ...